Sale!

CRYM Gene Deafness Autosomal Dominant Type 40 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CRYM Gene Deafness Autosomal Dominant Type 40 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the CRYM gene that are associated with Autosomal Dominant Non-Syndromic Hearing Loss (ADNSHL) type 40. This condition, which can affect individuals of any age, is characterized by varying degrees of hearing impairment that can range from mild to profound. The test is crucial for early detection and management of the condition, enabling healthcare providers to offer appropriate interventions and support for affected individuals and their families.

Conducted through a simple yet sophisticated process that involves the collection and analysis of a DNA sample, typically obtained via a blood draw or cheek swab, the test scrutinizes the CRYM gene for specific genetic alterations known to contribute to this form of hearing loss. By identifying these mutations, the test not only confirms a diagnosis but also helps in understanding the inheritance pattern within a family, thereby aiding in future family planning and providing insights into the condition’s progression and potential treatments.

The cost of the CRYM Gene Deafness Autosomal Dominant Type 40 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis necessary to provide a detailed and accurate understanding of an individual’s genetic predisposition to this form of deafness, offering invaluable information for affected individuals and their healthcare providers.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CRYM Gene Deafness autosomal dominant type 40 Genetic Test

At DNA Labs UAE, we offer the CRYM Gene Deafness autosomal dominant type 40 Genetic Test for individuals who may be experiencing symptoms of hearing loss. This test helps in identifying any mutations or variations in the CRYM gene, which is associated with autosomal dominant type 40 (DFNA40) deafness.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the CRYM Gene Deafness autosomal dominant type 40 Genetic Test, it is important to provide the clinical history of the patient. This includes information about any symptoms related to CATSPER2 Gene Deafness and male infertility. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by CATSPER2 Gene Deafness and male infertility. This session may also involve genetic testing for the CATSPER2 gene and the CATSPER5 gene.

Test Details

The CRYM gene is specifically associated with autosomal dominant type 40 (DFNA40) deafness. This means that an individual only needs to inherit one copy of the mutated gene from either parent to develop the condition. The CRYM gene can be analyzed using Next-Generation Sequencing (NGS) technology, which allows for the sequencing of multiple genes simultaneously. By analyzing the CRYM gene, any mutations or variations that may be present can be identified.

Genetic testing for DFNA40 is beneficial in confirming a diagnosis for individuals with symptoms of hearing loss. It can also help identify carriers of the mutated gene within families and provide valuable information for genetic counseling and family planning.

It is important to consult with a healthcare professional or genetic counselor to determine if NGS testing for the CRYM gene is appropriate for your specific situation. They can provide more detailed information about the test, its benefits, limitations, and potential implications.

Test Name CRYM Gene Deafness autosomal dominant type 40 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER5
Test Details

The CRYM gene is associated with deafness, specifically autosomal dominant type 40 (DFNA40). Autosomal dominant means that an individual only needs to inherit one copy of the mutated gene from either parent to develop the condition.

NGS (Next-Generation Sequencing) is a genetic testing method that allows for the sequencing of multiple genes simultaneously. In the context of deafness, NGS can be used to analyze the CRYM gene and identify any mutations or variations that may be present.

Genetic testing for DFNA40 can help confirm a diagnosis in individuals with symptoms of hearing loss. It can also be useful for identifying carriers of the mutated gene within families, as well as providing information for genetic counseling and family planning.

It’s important to consult with a healthcare professional or genetic counselor to determine if NGS testing for the CRYM gene is appropriate for your specific situation. They can provide more detailed information about the test, its benefits, limitations, and potential implications.